Figure 3. Survival Of All Randomized Aids Patients Over Time In Trial 3 (Clarithromycin Fig1)
Clarithromycin Tablet, Film Coated
Product Images NDC 57237-045
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 57237-045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package Label-principal Display Panel (250 mg (60 Tablets Bottle))
Package Label-principal Display Panel (500 mg (60 Tablets Bottle))
Each film-coated tablet of ™Risine®_045.6 contains 500mg of Clarithromycin USP. The usual adult dose is mentioned in the enclosure. The product is distributed by Rising Health, LLC and made in India. The revised date of the text is December 2017. The tablets should be stored in a light-resistant container within 15° to 30°C. This text contains printing zone coding area at the end.*
Structure (Clarithromycin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
